Detalhe da pesquisa
1.
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Nat Genet
; 31(1): 55-9, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-11967536
2.
Prevalence of the variant allele rs61764370 T>G in the 3'UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer families.
Breast Cancer Res Treat
; 128(1): 79-84, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20676756
3.
Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
J Clin Oncol
; 21(9): 1675-81, 2003 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12721241
4.
Selection bias influences reported contralateral breast cancer incidence and survival in high risk non-BRCA1/2 patients.
Breast Cancer Res Treat
; 95(2): 117-23, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16319990